Literature DB >> 21600369

Nonpharmacologic complementary therapies in symptom management for breast cancer survivors.

Anne H Blaes1, Mary Jo Kreitzer, Carolyn Torkelson, Tufia Haddad.   

Abstract

The request and use of nonpharmacologic interventions and complementary and alternative medicine (CAM) in cancer survivors is increasing. Given the large number of breast cancer survivors and the multiple treatment-related symptoms they endure, it is important for physicians to be aware of the evidence supporting nonpharmacologic therapies. Several studies evaluating such interventions have demonstrated improved overall quality of life (QOL). For other symptoms, the literature is limited but growing. We summarize the evidence to support complementary and alternative therapies for the major symptoms in breast cancer survivors.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21600369     DOI: 10.1053/j.seminoncol.2011.03.009

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  8 in total

1.  Prevalence of traditional, complementary, and alternative medicine use by cancer patients in low income and lower-middle income countries.

Authors:  Jacob Hill; Coleman Mills; Quefeng Li; Jennifer S Smith
Journal:  Glob Public Health       Date:  2018-10-16

2.  Development and Validation of a Standardized Questionnaire and Standardized Diary for Use in Integrative Medicine Consultations in Gynecologic Oncology.

Authors:  C C Hack; N B M Hüttner; P A Fasching; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

Review 3.  Local and Systemic Therapies for Breast Cancer Patients: Reducing Short-term Symptoms with the Methods of Integrative Medicine.

Authors:  C C Hack; P Voiß; S Lange; A E Paul; S Conrad; G J Dobos; M W Beckmann; S Kümmel
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-07       Impact factor: 2.915

4.  Breast cancer survivorship symptom management: current perspective and future development.

Authors:  G van Londen; Eb Beckjord; Ma Dew; P Cuijpers; S Tadic; A Brufsky
Journal:  Breast Cancer Manag       Date:  2013-01

5.  Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients.

Authors:  Nikolas Schuerger; Evelyn Klein; Alexander Hapfelmeier; Marion Kiechle; Christine Brambs; Daniela Paepke
Journal:  Breast Care (Basel)       Date:  2018-10-23       Impact factor: 2.860

6.  Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.

Authors:  Carolin C Hack; Peter A Fasching; Tanja Fehm; Johann de Waal; Mahdi Rezai; Bernd Baier; Gerold Baake; Hans-Christian Kolberg; Martin Guggenberger; Mathias Warm; Nadia Harbeck; Rachel Wuerstlein; Jörg-Uwe Deuker; Peter Dall; Barbara Richter; Grischa Wachsmann; Cosima Brucker; Jan W Siebers; Nikos Fersis; Thomas Kuhn; Christopher Wolf; Hans-Walter Vollert; Georg-Peter Breitbach; Wolfgang Janni; Robert Landthaler; Andreas Kohls; Daniela Rezek; Thomas Noesslet; Gunnar Fischer; Stefan Henschen; Thomas Praetz; Volker Heyl; Thorsten Kühn; Thomas Krauss; Christoph Thomssen; Andre Hohn; Hans Tesch; Christoph Mundhenke; Alexander Hein; Claudia Rauh; Christian M Bayer; Adib Jacob; Katja Schmidt; Erik Belleville; Peyman Hadji; Sara Y Brucker; Diethelm Wallwiener; Sherko Kümmel; Matthias W Beckmann; Daniela Paepke
Journal:  Integr Cancer Ther       Date:  2016-09-14       Impact factor: 3.279

7.  Self-reported Improvement in Side Effects and Quality of Life With Integrative Medicine in Breast Cancer Patients.

Authors:  Carolin C Hack; Janina Hackl; Nina B M Hüttner; Hanna Langemann; Judith Schwitulla; Svenja Dietzel-Drentwett; Peter A Fasching; Matthias W Beckmann; Anna-Katharin Theuser
Journal:  Integr Cancer Ther       Date:  2018-05-30       Impact factor: 3.279

8.  A Systematic Review and Quality Assessment of Breast Cancer Clinical Practice Guidelines Providing Complementary and Alternative Medicine Recommendations.

Authors:  Jeremy Y Ng; Hosna Sahak; Stephanie Ka Ching Lau
Journal:  Curr Oncol Rep       Date:  2021-08-03       Impact factor: 5.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.